Surveillance in cholangiocellular carcinoma.
1Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, 30625 Hannover, Germany.
Best Practice & Research. Clinical Gastroenterology
|December 13, 2016
Summary
Cholangiocarcinoma (bile duct cancer) incidence is rising, with poor survival rates. Early detection through surveillance in high-risk groups, like those with primary sclerosing cholangitis or liver fluke infections, is crucial.
Area of Science:
- Hepatobiliary Medicine
- Surgical Oncology
- Gastroenterology
Background:
- Cholangiocarcinoma is a prevalent bile duct cancer with increasing incidence.
- High mortality and low 5-year survival rates (below 20%) underscore treatment challenges.
- Current curative options are limited to surgery, with palliative chemotherapy for advanced cases.
Purpose of the Study:
- To review current surveillance strategies for cholangiocarcinoma.
- To identify high-risk populations requiring targeted screening.
- To summarize available detection methods for early cholangiocarcinoma diagnosis.
Main Methods:
- Literature review of existing data on cholangiocarcinoma surveillance.
- Analysis of risk factors and associated populations.
- Evaluation of diagnostic methods for cholangiocarcinoma detection.
Main Results:
- Incidence of cholangiocarcinoma has increased significantly over recent decades.
- Patients with primary sclerosing cholangitis and liver fluke infections are at elevated risk.
- Effective surveillance strategies are needed to improve outcomes.
Conclusions:
- Urgent need for robust surveillance protocols for at-risk populations.
- Early detection through improved screening methods is paramount.
- Further research into surveillance and early detection of cholangiocarcinoma is warranted.
